Several methods, giving values essentially in agreement, are now available to determine the iodine content-of plasma. Attempts to quantitate the iodine content of tissues have not yielded consistent results. The purpose of our paper is to report the application to this problem of a method based on isotopic equilibrium and using 1125 as a radioactive tracer. With this procedure, it is possible to measure the concentration of total iodine, iodide, thyroxine, triiodothyronine, and some unidentified iodine-containing substances in plasma, selected tissues, and excreta of the rat.
Several methods, giving values essentially in agreement, are now available to determine the iodine content-of plasma. Attempts to quantitate the iodine content of tissues have not yielded consistent results. The purpose of our paper is to report the application to this problem of a method based on isotopic equilibrium and using 1125 as a radioactive tracer. With this procedure, it is possible to measure the concentration of total iodine, iodide, thyroxine, triiodothyronine, and some unidentified iodine-containing substances in plasma, selected tissues, and excreta of the rat.
METHODS
Diets. Rats were fed two separate diets differing in their iodine content. The first, designated "high-iodine," consisted of a standard laboratory diet 1 containing 1.7 ,ug of iodine 2 per g of ration; the second, designated "low-iodine," was a special low-iodine ration 3 containing 0.06 /Ag of iodine 2 per g. To avoid the possibility of producing iodine deficiency (1), we added enough potassium iodide to raise the iodine content to 0.22 /Ag per g. The amount of iodine added to the diets as I"5 was negligible. The two diets, therefore, differed approximately tenfold in iodine concentration. Enough feed was obtained from the manufacturers to complete all the experiments with one lot, avoiding variations in the stable-iodine content.
I"25 was obtained carrier free from a commercial source. 4 mixing. It was necessary to regrind the mixture and mix it again before satisfactory agreement between radioactivity of samples was obtained (Table I , batches no. 1 and 2). With the following procedure, we obtained excellent results. An appropriate amount of radioactive iodine (usually 10 mc) was diluted to 150 to 200 ml with distilled water, added to several hundred g of ground feed, and thoroughly mixed. The mixture was dried in an oven and passed through a grinding mill to obtain a finely pulverized material. This was added to the remaining feed, which also had been finely ground, and the entire amount was mixed in a single bulk feed mixer for 18 to 24 hours. Fifteen 0.5-g portions were randomly sampled from the mixture, and the radioactivity was measured in a well-type scintillation detector to check the completeness of mixing and to establish the I...: I"1 ratio. The improved dispersion of the label is clear from the data presented in Table  I (batches no. 3-9). Preparation of tissue. Male albino rats (Holtzman) weighing 200 to 600 g were used in all experiments. To avoid an abrupt change in total iodine intake when the feeding of labeled diet began, we first maintained the rats on the appropriate test diet, but without the radioactive iodine, for 4 to 8 weeks.
After the initiation with labeled diet, the animals were sacrificed at intervals by exsanguination under ether anesthesia. The tissues were immediately excised, blotted free of residual blood, rinsed with water, and chilled on ice. Either whole small organs or 1 to 2 g of tissues were weighed to ± 10 mg and counted in a welltype scintillation counter. A sample of the diet was counted at the same time to correct for physical decay and instrument variation. For 24 hours before sacri- (3) . Some samples were also chromatographed in a butanol-ethanol-ammonia system (4) . Urine was chromatographed directly. Colorimetrically identifiable quantities of marker compounds were added to the extract before chromatography. The position of the thyronine compounds was determined with 4-amino-antipyrine reagent (5) and iodide with palladium chloride reagent (4) . The radioactivity was localized on the chromatograms by scanning with a 4-pi anticoincidence gas-flow counter equipped with a continuously recording system.5 Argon was used as the counting gas and isobutane as the internal quencher. The radioactivity was quantitated by planimetry of the area under the curve and by use of an automatic integrator attached to the scanner assembly. Radioautographs of the same strips were also prepared by use of Kodak nonscreen X-ray film to confirm the findings by scanning and to detect bands of low levels of radioactivity that might have been overlooked. 5 Scanogrator III, Atomic Accessories, Inc., Valley Stream, N. Y. 
EXTRATHYROIDAL IODINE COMPOUNDS
The labeled diet was continued until there was essentially no further increase in total radioactivity, after correction for physical decay, in any of the excised tissues. At this point, the rats were considered to be in a state of equilibrium with their diet in respect to rel%-tive I125 and I' concentrations. The remaining rats were killed and their tissues processed as above. This provided a larger number of animals for statistical study.
Histological sections were prepared from thyroids of rats selected at random in order to evaluate any radiation damage to the thyroids. In all instances, the thyroid follicles appeared normal. 6 6 We are in debt to Dr. Joseph J. Lalich of the Department of Pathology for these studies. 
RESULTS
The appearance of the radioactive label in the tissues, plasma, and excreta is shown in Figure 1 . The ordinates reflect cumulative radioactivity. The radioactivity in all tissues increases rapidly for the first few days and then levels off. Since the labeled iodine will be continuously diluted by the stable iodine present in the body when feeding of the labeled diet begins, true equilibrium will be approached asymptotically. Very little increase in radioactivity in any of the tissues was observed UITE$TI
-wsci. Peaks appeared that and urine is given in Tables II (high-iodine le, thyroxine, and tri-group) and III (low-iodine group). The major difference between these two groups is in the amount of iodine in the origin material and as iodide. Both origin iodine and iodide were much higher in all tissues examined in the high-iodine group. The large amount of radioactivity as iodide on the chromatograms in the high-iodine group raised the background level to the point that accurate measurement of the radioactivity present as thyroxine and triiodothyronine was not feasible. For this reason, the low-iodine group was selected for quantitation of thyroxine and triiodothyronine.
Among tissues examined (Table III) , thyroxine iodine was in highest concentration in liver and kidney, and in lowest concentration in skeletal muscle and brain. Triiodothyronine iodine was most abundant in kidney and small intestine and least abundant in muscle and testis. The relative concentration of triiodothyronine to thyroxine expressed as the T3: To ratio was the lowest in testis (0.13), fat (0.18), and liver (0.18) and highest in brain (0.82). This ratio in most tissues varied from approximately 0.4 to 0.6.
Thyroxine iodine concentration in plasma ( Table  III ) greatly exceeded that found in tissues, being twice that of liver and eighteen times that of skeletal muscle. Triiodothyronine iodine concentration, on the other hand, was less in plasma than in any tissue with the possible exception of skeletal muscle and testis. The total iodine in plasma according to this method was 33.1 mug per ml. The protein-bound iodine determined by a standard method was 31.0 mpug per ml (3.1 ,ug per 100 ml).
The pattern of excretion of labeled substances reflected the dietary intake of I125. Fifteen times as much radioactivity, almost exclusively iodide, appeared in the urine of the high-iodine group as in that of the low-iodine group. Correspondingly, six times as much radioactivity appeared in the feces. According to the data obtained from the low-iodine group, fecal radioactivity was distributed between thyroxine (37%o), triiodothyronine (20%), iodide (30%c), origin material (5%o), and remainder, including triiodo-and tetraiodothyroacetic acid (8%).
DISCUSSION
For the measurement of iodine in tissues, Van Middlesworth reported a method involving feeding I131-labeled diet until equilibrium was established between the SA of the diet and the SA of all the iodine pools of the animals. At equilibrium, the 1131 in any pool or in any compound was assumed to be proportional to its total iodine content. This procedure was applied by Van Middlesworth (7) and by Pitt-Rivers and Rall (8) to the measurement of various iodine pools. The use of 1131 as a label for this purpose is limited by its relatively short half life (8 days) . Van With the latter, counting efficiency is greatly increased by using argon-isobutane instead of the more standard helium mixtures.
Our method depends upon the establishment of equilibrium between the SA of the diet and all of the iodine pools in the body. We recognize that the tracer will be continuously "diluted" by the stable iodine present in the body at the beginning of the feeding; therefore, the SA in the body will approach the SA of the diet asymptotically, and true equilibrium will not be achieved. Absolute equilibrium is not essential, however, for useful estimations. Any value in excess of 90% equilibrium for all iodine pools should be adequate for our purpose.
Van Middlesworth and Intoccia (10) concluded that equilibrium was reached between 5 and 50 days, depending on the iodine content of the diet.
Pitt-Rivers and Rall (8) Barker (14) , was applied to tissues by Carr and Riggs (15) and by Klitgaard, Dirks, Garlick, and Barker (16) , with highly divergent results, possibly owing to variation in the total iodine content of experimental diets. These as- Triiodothyronine was consistently present in all tissues, and with the possible exception of skeletal muscle, in higher concentration than in plasma. This suggests either that the triiodothyronine is formed intracellularly, or that there is a trapping mechanism responsible for this concentration gradient. The very high concentration of triiodothyronine in kidney, together with previous evidence that this tissue has the most active thyroxine monodeiodinase activity (17) , lends support to the first hypothesis. On the other hand, triiodothyronine injected intravenously does accumulate in certain organs, reaching levels 10 hours after injection that are higher than in plasma (18) . Moreover, the organs in which the highest levels were attained were the same as were observed in our study (i.e., kidney, small intestine, and liver). Studies are underway to determine the order of appearance and disappearance of the labeled compounds at the time of starting and stopping the labeled diet, respectively. This may yield information bearing on the question of the origin of triiodothyronine.
SUMMARY
An isotope-equilibrium method using an 1125_ labeled diet of known total iodine content is described for the quantitative estimation of total iodine and iodine-containing compounds in body tissues, plasma, and excreta of the rat.
Radiochromatograms of plasma, feces, and tissues revealed iodide, thyroxine, and triiodothyronine. The feces, in addition, contained small amounts of triiodo-and tetraiodothyroacetic acid. Urine contained virtually only iodide. Although most of the radioactivity was associated with these known compounds, several unknown peaks of varying mobility were observed.
The calculated concentration of thyroxine iodine in tissues ranged from 1 mug per g in muscle and brain to 11 mpg per g in liver. Plasma contained 22 mpug per ml. The concentration of triiodothyronine iodine in tissues ranged from 0.4 mpg per g in testis and muscle to 5 mpg per g in kidney. Plasma contained 0.7 mpg per ml. Concentration of total iodine, iodide, and certain unknown compounds varied with total iodine content of the diet.
